Skip to main content

Table 2 Patient and outcome characteristics in the four outcome groups

From: Development of a biophysical screening model for gestational hypertensive diseases

 

Normotensive Pregnancy (NP) (n = 897)

Early-onset Preeclampsia (EPE) (n = 8)

Late-onset Preeclampsia (LPE) (n = 29)

Gestational Hypertension (GH) (n = 35)

Characteristics at inclusion

 Maternal age, years

30 (27–33)

30 (25–36)

30 (27–34)

30 (27–33)

 Pregestational maternal weight, kg

64 (58–74)

76 (64–84)*

66 (62–82)

65 (59–79)

 Pregestational maternal height, cm

166 (161–170)

166 (163–170)

166 (165–170)

167 (162–170)

 Pregestational BMI, kg/m2

23,3 (21–26,8)

27,3 (23,3-29,8)

24,1 (22,4-30,2)

23,6 (22–27,9)

Gestational age at assessment, weeks+days

 First trimester

12w2d (11w5d-12w5d)

13w (12w3d-13w2d)*

11w5d (11w1d-12w5d)*

12w2d (11w6d-12w5d)

 Second trimester

20w2d (19w6d-20w5d)

21w (20w3d-26w3d)*

20w5d (20w1d-21w4d)*

20w2d (19w5d-20w6d)

Medical history

 Diabetes Mellitus

116 (12,9%)

2 (25%)

6 (20,7%)

6 (17,1%)

 Thrombophilia

33 (3,7%)

1 (12,5%)

1 (3,4%)

2 (5,7%)

 Allergy

177 (19,7%)

0 (0%)

4 (13,8%)

13 (37,1%)*

Obstetric history

 Intra-Uterine Death

15 (1,7%)

0 (0%)

1 (3,4%)

1 (2,9%)

 Intra-Uterine Growth Restriction

7 (0,8%)

0 (0%)

0 (0%)

1 (2,9%)

 Nulliparity

472 (52,6%)

4 (50%)

8 (27,6%)*

14 (40%)

Hypertension

 Family history

41 (4,6%)

1 (12,5%)

1 (3,4%)

2 (5,7%)

 Previous pregnancy

55 (6,1%)

2 (25%)

4 (13,8%)

10 (28,6%)*

Outcome characteristics

 Birth weight, g

3425 (3145–3734)

1300 (572–1712)*

3230 (2690–3656)*

3405 (3040–3720)

 Birth weight, percentile

57,5 (33–77,5)

7,5 (3,8-48,8)

63,8 (28,1-79,4)

52,5 (23,5-82,5)

 Gestational age at delivery, weeks + days

39w5d (38w5d-40w3d)

31w5d (27w-32w5d)*

37w5d (36w5d-39w6d)*

39w3d (38w5d-40w5d)

  1. Data are presented as median (IQR) or n (%)
  2. *p<0,05 was considered significant different from normotensive pregnancy (NP)